CDEK
← All organizations

Gloucester Pharmaceuticals

For profitContributed to NME

Also known as: Gloucester Pharmaceuticals, Inc.

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 2

First clinical trial

May 1, 2003

First marketed drug

Nov 5, 2009

First NDA

Nov 5, 2009

Last known activity

Jan 1, 2005

Acquired by Celgene → Bristol-Myers Squibb on Jan 15, 2009

Timeline

2000s

  1. Jan 1, 2003

    Gloucester Pharmaceuticals— Founded

  2. Jan 15, 2009

    Celgene— Acquired By

  3. Nov 5, 2009

    romidepsin— NDA Organization

2010s

  1. Jan 3, 2019

    Bristol-Myers Squibb— Now

Drugs by trial phase (1 distinct, 3 trials)

Phase 2 (1 own, 0 via acquisition)

Indications

Approved for

Studied for

Marketed drugs (1)

Recent trials (3)

Details

Founded
Cambridge, MA, US Jan 1, 2003
First NDA
Nov 5, 2009
Last known activity
Jan 1, 2005

Designations held

  • Orphan drug

Notes

Acquired by Celgene 7 Dec 2009